Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$7.56
NASDAQLPCN
Open
$7.81
Change
-$0.16 (-2.07%)
Day's Range
$7.33 - $7.90
52-Week Range
$2.31 - $11.79
Volume
33.7K
Market Cap
$40.4M
Currency in USD.
Quote data delayed by at least 15 minutes.